GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...

MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2026. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Phase II trial of MEDI0457 and durvalumab for patients with recurrent/metastatic HPV-associated cancers. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not ...